• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (5): 782-786.DOI: 10.3969/j.issn.1671-2587.2026.05.017

• 个例报告 • 上一篇    下一篇

亚甲蓝达安全上限后全血置换救治敌稗中毒铁血红蛋白血症一例*

肖昆1, 廖玉龙2, 余佩2, 刘军2, 黄梦贞2, 肖飞3, 曾嘉琪3, 范芹3, 杨楠3, 乐爱平1   

  1. 1南昌大学第一附属医院输血医学科, 输血医学江西省重点实验室,江西南昌 330006;
    2赣江新区人民医院重症医学科,江西南昌 330029;
    3赣江新区人民医院输血医学科,江西南昌 330029
  • 收稿日期:2026-09-02 修回日期:2026-09-30 出版日期:2026-10-20 发布日期:2026-11-11
  • 通讯作者: 乐爱平,主要从事临床输血研究,(E-mail)ndyfy00973@ncu.edu.cn。
  • 作者简介:肖昆,主要从事临床输血研究,(E-mail)ndyfy04024@ncu.edu.cn。
  • 基金资助:
    *本课题受国家自然科学基金(No.82360045)资助

Therapeutic Whole Blood Exchange for Propanil-Induced Methemoglobinemia after Methylene Blue Reached the Maximum Safe Cumulative Dose: A Case Report

XIAO Kun1, LIAO Yulong2, YU Pei2, LIU Jun2, HUANG Mengzhen2, XIAO Fei3, ZENG Jiaqi3, FAN Qin3, YANG Nan3, LE Aiping1   

  1. 1Department of Transfusion Medicine, Key Laboratory of Jiangxi Province for Transfusion Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, 330006;
    2Department of Intensive Care Unit, Ganjiang New Area People's Hospital, Nanchang 330029;
    3Department of Transfusion Medicine, Ganjiang New Area People's Hospital, Nanchang 330029
  • Received:2026-09-02 Revised:2026-09-30 Online:2026-10-20 Published:2026-11-11

摘要: 报告1例采用全血置换(TBE)救治敌稗中毒致高铁血红蛋白血症(MetHb)的临床经过。患者为50岁女性,亚甲蓝累计剂量约8 mg/kg,已超过文献建议的累计用量上限7 mg/kg。虽MetHb由17.8%降至5.5%,但患者仍昏迷、发绀;考虑继续追加亚甲蓝可能增加反常性MetHb升高及溶血风险,经多学科会诊后停止追加,实施TBE,在一次连续治疗中先行治疗性血浆置换(TPE),再行红细胞置换(RBCX),完成血浆及红细胞两种主要血液组分的移除与补充。TBE术中MetHb为3.6%,术后1 h和12 h均为4.4%,术后21 h降至2.0%,36 h降至0.5%;术中SpO2升至97%~98%。术后24 h患者神志转清并拔除气管插管,术中生命体征平稳,未发生严重输血不良反应。本例提示,在亚甲蓝继续使用受限且患者仍有严重临床表现时,TBE可作为个体化挽救方案。由于亚甲蓝已使MetHb明显下降,且同期存在机械通气等综合治疗,本病例不能单独确定TBE的疗效,仍需更多病例验证其适用条件、置换剂量和安全性。

关键词: 敌稗中毒, 高铁血红蛋白血症, 亚甲蓝, 全血置换, 多学科协作团队

Abstract: We report a case of therapeutic whole blood exchange (TBE) for propanil-induced methemoglobinemia (MetHb) after the cumulative dose of methylene blue (MB) exceeded the recommended limit. The patient was a 50-year-old woman who received a cumulative MB dose of approximately 8 mg/kg, exceeding the recommended cumulative limit of 7 mg/kg. Although MetHb decreased from 17.8% to 5.5%, she remained comatose and cyanotic. Given the risk of paradoxical worsening of methemoglobinemia and hemolysis with further MB, additional dosing was withheld following multidisciplinary consultation, and TBE was performed. In this case, TBE consisted of therapeutic plasma exchange (TPE) followed by red blood cell exchange (RBCX) within one continuous treatment session to remove and replace both plasma and red blood cells. MetHb was 3.6% during TBE, 4.4% at 1 and 12 hours after TBE, 2.0% at 21 hours, and 0.5% at 36 hours. Intraoperative SpO2 increased to 97%~98%. The patient regained consciousness and was extubated at 24 hours after TBE. Vital signs remained stable during the procedure, and no serious transfusion-related adverse reactions occurred. This case suggests that TBE may be considered as an individualized rescue regimen when further MB administration is limited by safety concerns and severe clinical manifestations persist. Because MB had already substantially reduced MetHb and the patient concurrently received mechanical ventilation and other supportive treatments, the independent efficacy of TBE cannot be established from this case. Further cases are needed to clarify its indications, exchange dose, and safety.

Key words: Propanil poisoning, Methemoglobinemia, Methylene blue, Therapeutic whole blood exchange, Multidisciplinary team

中图分类号: